SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Smith Cally) "

Search: WFRF:(Smith Cally)

  • Result 1-3 of 3
Sort/group result
   
EnumerationReferenceCoverFind
1.
  • Adjuik, Martin A., et al. (author)
  • The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria : a meta-analysis of individual patient data
  • 2015
  • In: BMC Medicine. - : Springer Science and Business Media LLC. - 1741-7015. ; 13
  • Journal article (peer-reviewed)abstract
    • Background: Artesunate-amodiaquine (AS-AQ) is one of the most widely used artemisinin-based combination therapies (ACTs) to treat uncomplicated Plasmodium falciparum malaria in Africa. We investigated the impact of different dosing strategies on the efficacy of this combination for the treatment of falciparum malaria. Methods: Individual patient data from AS-AQ clinical trials were pooled using the WorldWide Antimalarial Resistance Network (WWARN) standardised methodology. Risk factors for treatment failure were identified using a Cox regression model with shared frailty across study sites. Results: Forty-three studies representing 9,106 treatments from 1999-2012 were included in the analysis; 4,138 (45.4%) treatments were with a fixed dose combination with an AQ target dose of 30 mg/kg (FDC), 1,293 (14.2%) with a non-fixed dose combination with an AQ target dose of 25 mg/kg (loose NFDC-25), 2,418 (26.6%) with a non-fixed dose combination with an AQ target dose of 30 mg/kg (loose NFDC-30), and the remaining 1,257 (13.8%) with a co-blistered non-fixed dose combination with an AQ target dose of 30 mg/kg (co-blistered NFDC). The median dose of AQ administered was 32.1 mg/kg [IQR: 25.9-38.2], the highest dose being administered to patients treated with co-blistered NFDC (median = 35.3 mg/kg [IQR: 30.6-43.7]) and the lowest to those treated with loose NFDC-25 (median = 25.0 mg/kg [IQR: 22.7-25.0]). Patients treated with FDC received a median dose of 32.4 mg/kg [IQR: 27-39.0]. After adjusting for reinfections, the corrected antimalarial efficacy on day 28 after treatment was similar for co-blistered NFDC (97.9% [95% confidence interval (CI): 97.0-98.8%]) and FDC (98.1% [95% CI: 97.6%-98.5%]; P = 0.799), but significantly lower for the loose NFDC-25 (93.4% [95% CI: 91.9%-94.9%]), and loose NFDC-30 (95.0% [95% CI: 94.1%-95.9%]) (P < 0.001 for all comparisons). After controlling for age, AQ dose, baseline parasitemia and region; treatment with loose NFDC-25 was associated with a 3.5-fold greater risk of recrudescence by day 28 (adjusted hazard ratio, AHR = 3.51 [95% CI: 2.02-6.12], P < 0.001) compared to FDC, and treatment with loose NFDC-30 was associated with a higher risk of recrudescence at only three sites. Conclusions: There was substantial variation in the total dose of amodiaquine administered in different AS-AQ combination regimens. Fixed dose AS-AQ combinations ensure optimal dosing and provide higher antimalarial treatment efficacy than the loose individual tablets in all age categories.
  •  
2.
  •  
3.
  • Sim, Angela, et al. (author)
  • Factors associated with stress in families of children with autism spectrum disorder
  • 2018
  • In: Developmental Neurorehabilitation. - : Taylor & Francis. - 1751-8423 .- 1751-8431. ; 21:3, s. 155-165
  • Journal article (peer-reviewed)abstract
    • Purpose: The purpose of this study was to identify key factors associated with severe stress in families raising a child with autism spectrum disorder (ASD). Methods: Questionnaires were mailed to families with one or more children with a diagnosis of ASD. Data from 543 surveys were analyzed using univariate and multivariate logistic regression. Results: Forty-four percent (n = 241) of the caregivers reported severe family stress related to raising a child with ASD. Severe family stress was associated with (1) reduced ability to socialize; (2) not having accessed individual therapy; (3) negative co-parent relationships; and (4) high out of pockets costs due to the child’s ASD. The specific ASD diagnosis, comorbid conditions, socio-demographic variables, and social support were not associated with severe family stress. Conclusion: The findings of the current study highlight the importance of a systemic approach to family stress, whereby individual, family, and ecological factors are investigated.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 1-3 of 3
Type of publication
journal article (3)
Type of content
peer-reviewed (3)
Author/Editor
Grommet, Angela Beth ... (1)
Checchi, Francesco (1)
Ashley, Elizabeth A. (1)
Bassat, Quique (1)
Bjorkman, Anders (1)
Borrmann, Steffen (1)
show more...
D'Alessandro, Umbert ... (1)
Dahal, Prabin (1)
Djimde, Abdoulaye A. (1)
Flegg, Jennifer A. (1)
Gonzalez, Raquel (1)
Guerin, Philippe J. (1)
Guthmann, Jean-Paul (1)
Juma, Elizabeth (1)
Moreira, Clarissa (1)
Ogutu, Bernhards R. (1)
Price, Ric N. (1)
Stepniewska, Kasia (1)
White, Nicholas J. (1)
Adjuik, Martin A. (1)
Allan, Richard (1)
Anvikar, Anupkumar R ... (1)
Ba, Mamadou S. (1)
Barennes, Hubert (1)
Barnes, Karen I. (1)
Baudin, Elisabeth (1)
Bompart, Francois (1)
Bonnet, Maryline (1)
Brasseur, Philippe (1)
Bukirwa, Hasifa (1)
Cot, Michel (1)
Deloron, Philippe (1)
Desai, Meghna (1)
Diap, Graciela (1)
Dorsey, Grant (1)
Doumbo, Ogobara K. (1)
Espie, Emmanuelle (1)
Etard, Jean-Francois (1)
Fanello, Caterina I. (1)
Faucher, Jean-Franco ... (1)
Faye, Babacar (1)
Gaye, Oumar (1)
Gething, Peter W. (1)
Grandesso, Francesco (1)
Hamour, Sally (1)
Hasugian, Armedy Ron ... (1)
Hay, Simon I. (1)
Humphreys, Georgina ... (1)
Jullien, Vincent (1)
Kamya, Moses R. (1)
show less...
University
Uppsala University (1)
Linköping University (1)
Jönköping University (1)
Chalmers University of Technology (1)
Karolinska Institutet (1)
Language
English (3)
Research subject (UKÄ/SCB)
Medical and Health Sciences (2)
Natural sciences (1)
Engineering and Technology (1)
Social Sciences (1)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view